Javascript must be enabled to continue!
An Investigation of Medical Examiner Cases in Which Methadone Was Detected, Harris County, Texas, 1987–1992
View through CrossRef
Abstract
In 1991, media reports of an increase in the number of deaths attributed to methadone toxicity in Harris County, Texas, raised public concern about the safety of methadone. This concern was heightened by publicity surrounding the closure of three Harris County methadone maintenance treatment programs due to their poor compliance with federal methadone regulations. In response to this concern, the Texas Department of Public Health requested that the Centers for Disease Control and Prevention (CDC) assist in an epidemiologic study to determine the extent of methadone-related mortality in Harris County during 1991 and to determine the role of methadone maintenance treatment in these deaths.
We reviewed cases investigated by the Harris County Medical Examiner's Office from 1987 through 1992 in which methadone was detected by postmortem drug testing. The autopsy reports for cases occurring in 1991 were also reviewed by three independent forensic pathologists who were asked to determine the role of methadone in the death. In addition, we attempted to document Harris County methadone maintenance treatment program enrollment for each decedent.
We identified 91 decedents in whom methadone was detected at the time of death, with the largest number of cases occurring in 1991 (n = 27). Other substances, including alcohol, were detected in 85% of the cases. The Harris County Medical Examiner attributed 11 of the deaths to methadone toxicity. No more than three cases per year from 1987 through 1992 were attributed to methadone toxicity. In contrast, 34 deaths were attributed to polydrug toxicity, the largest number occurring in 1991 (n = 11). There was good agreement between the results of the independent review and the opinions of the Harris County Medical Examiner. Only 20% of the decedents were found to have been enrolled in a Harris County methadone maintenance treatment program at the time of death. Four people died of drug toxicity shortly after enrolling in a methadone maintenance treatment program.
We found an increase in the number deaths occurring in Harris County, Texas, in 1991 in which methadone was detected. We also found that methadone blood levels were higher among decedents identified for 1991 and 1992 than among those identified in the previous years studied. However, we did not find evidence that the cause of these deaths could be attributed solely to methadone toxicity. Instead, for all years studied, the use of multiple drugs was the leading cause of death among people in whom methadone was detected. This finding points out the difficulties involved in determining the role of methadone as a cause of death.
ASTM International
Title: An Investigation of Medical Examiner Cases in Which Methadone Was Detected, Harris County, Texas, 1987–1992
Description:
Abstract
In 1991, media reports of an increase in the number of deaths attributed to methadone toxicity in Harris County, Texas, raised public concern about the safety of methadone.
This concern was heightened by publicity surrounding the closure of three Harris County methadone maintenance treatment programs due to their poor compliance with federal methadone regulations.
In response to this concern, the Texas Department of Public Health requested that the Centers for Disease Control and Prevention (CDC) assist in an epidemiologic study to determine the extent of methadone-related mortality in Harris County during 1991 and to determine the role of methadone maintenance treatment in these deaths.
We reviewed cases investigated by the Harris County Medical Examiner's Office from 1987 through 1992 in which methadone was detected by postmortem drug testing.
The autopsy reports for cases occurring in 1991 were also reviewed by three independent forensic pathologists who were asked to determine the role of methadone in the death.
In addition, we attempted to document Harris County methadone maintenance treatment program enrollment for each decedent.
We identified 91 decedents in whom methadone was detected at the time of death, with the largest number of cases occurring in 1991 (n = 27).
Other substances, including alcohol, were detected in 85% of the cases.
The Harris County Medical Examiner attributed 11 of the deaths to methadone toxicity.
No more than three cases per year from 1987 through 1992 were attributed to methadone toxicity.
In contrast, 34 deaths were attributed to polydrug toxicity, the largest number occurring in 1991 (n = 11).
There was good agreement between the results of the independent review and the opinions of the Harris County Medical Examiner.
Only 20% of the decedents were found to have been enrolled in a Harris County methadone maintenance treatment program at the time of death.
Four people died of drug toxicity shortly after enrolling in a methadone maintenance treatment program.
We found an increase in the number deaths occurring in Harris County, Texas, in 1991 in which methadone was detected.
We also found that methadone blood levels were higher among decedents identified for 1991 and 1992 than among those identified in the previous years studied.
However, we did not find evidence that the cause of these deaths could be attributed solely to methadone toxicity.
Instead, for all years studied, the use of multiple drugs was the leading cause of death among people in whom methadone was detected.
This finding points out the difficulties involved in determining the role of methadone as a cause of death.
Related Results
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects
Study Objective. To investigate the steady‐state pharmacokinetics of methadone enantiomers when coadministered with amprenavir.Design. Prospective, open‐label, within‐subject pharm...
Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers
Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers
The respiratory and pupillary effects of oral l‐, d‐, and d,l‐methadone were studied in healthy male volunteers 21 to 35 yr of age. The mean half‐life of drug in blood was 22 hr fo...
Gender‐Specific Differences in Susceptibility to Low‐Dose Methadone‐Associated QTc Prolongation in Patients with Heroin Dependence
Gender‐Specific Differences in Susceptibility to Low‐Dose Methadone‐Associated QTc Prolongation in Patients with Heroin Dependence
Methadone and QT Prolongation. Background: Methadone is associated with QTc prolongation and sudden death in susceptible patients. We sought to investigate whether there is a gende...
Pharmacists' provision of methadone to intoxicated clients in community pharmacies, Victoria, Australia
Pharmacists' provision of methadone to intoxicated clients in community pharmacies, Victoria, Australia
AbstractThis paper concerns pharmacists dispensing methadone to intoxicated clients, drawing on both questionnaire and focus‐group data from a 1996 evaluation of the community‐base...
Improvement of Methadone Maintenance Treatment (MMT) Process Through Development and Implementation of Methadone Dispenser
Improvement of Methadone Maintenance Treatment (MMT) Process Through Development and Implementation of Methadone Dispenser
Abstract
Methadone is a controlled drug and can be prescribed by an authorized person in charge, under the direction of medical practitioners, for particular patient...
Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment
Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment
Objective:
Methadone treatment is effective for managing opioid use disorder (OUD) but raises concerns about its impact on cardiac function. This study aimed to assess ...
First-Line Methadone For Cancer Pain. Titration Time Analysis
First-Line Methadone For Cancer Pain. Titration Time Analysis
Abstract
Background. Methadone is a low-cost, strong opioid that is increasingly used as a first-line treatment for pain in palliative care (PC). Its long and unpredictable...
Overdose deaths attributed to methadone and heroin in New York City, 1990–1998
Overdose deaths attributed to methadone and heroin in New York City, 1990–1998
ABSTRACTAims Methadone treatment has been shown to be an effective intervention that can lower the risk of heroin‐induced overdose death. Recent reports have suggested increases i...

